The effect of aspartame administration on oncogene and suppressor gene expressions

In Vivo. 2007 Jan-Feb;21(1):89-92.

Abstract

Background: Aspartame (L-phenylalanine N-L-alpha-aspartyl-1-methyl ester) is an artificial sweetener with widespread applications. Previously published results have shown that among rats receiving aspartame a significant increase of lymphoreticular neoplasms, brain tumours and transitional cell tumours occurred. The aim of our short-term experiment was to investigate the biological effect of aspartame consumption by determining the expressions of key oncogenes and a tumour suppressor gene.

Materials and methods: After one week per os administration of various doses of aspartame to CBA/CA female mice, p53, c-myc, Ha-ras gene expression alterations were determined in individual organs.

Results: The results showed an increase in gene expressions concerning all the investigated genes especially in organs with a high proliferation rate: lymphoreticular organs, bone-marrow and kidney.

Conclusion: Aspartame has a biological effect even at the recommended daily maximum dose.

MeSH terms

  • Animals
  • Aspartame / adverse effects*
  • Female
  • Gene Expression Regulation
  • Genes, ras*
  • Mice
  • Mice, Inbred Strains
  • Organ Specificity
  • Proto-Oncogene Proteins c-myc / biosynthesis*
  • Sweetening Agents / adverse effects*
  • Tumor Suppressor Protein p53 / biosynthesis*

Substances

  • Myc protein, mouse
  • Proto-Oncogene Proteins c-myc
  • Sweetening Agents
  • Tumor Suppressor Protein p53
  • Aspartame